Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | NOTUM | Q6P988 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | KCNJ1 | P48048 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12379764 | 0.96 | ALDH1A1 (0.42) | ALDH1A1KMT2ATSHRNOTUMHTT | |
| SCHEMBL2289284 | 0.83 | NOTUM (0.52) | ALDH1A1KMT2ANOTUMHTTF2 | |
| SCHEMBL12379777 | 0.78 | NOTUM (0.53) | ALDH1A1KMT2ANOTUMHTTF2 | |
| SCHEMBL12379760 | 0.74 | NOTUM (0.53) | ALDH1A1KMT2ANOTUMHTTF2 | |
| SCHEMBL2048542 | 0.65 | ALDH1A1 (0.62) | ALDH1A1KMT2ATSHRNOTUMHTT | |
| SCHEMBL6244401 | 0.64 | NOTUM (0.50) | ALDH1A1KMT2ANOTUMHTTF2 | |
| SCHEMBL28643711 | 0.64 | ALDH1A1 (0.53) | ALDH1A1KMT2ATSHRNOTUMLMNA | |
| SCHEMBL17725605 | 0.64 | NOTUM (0.52) | ALDH1A1KMT2ANOTUMHTTF2 | |
| SCHEMBL1570379 | 0.63 | ALDH1A1 (0.51) | ALDH1A1KMT2ATSHRNOTUMHTT | |
| SCHEMBL2721346 | 0.63 | ALDH1A1 (0.64) | ALDH1A1KMT2ATSHRNOTUMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8002915-B2 | Gas generant compositions | TK HOLDINGS, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-8002915-B2 | Gas generant compositions | TK HOLDINGS, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-20090008002-A1 | Gas generant compositions | JOYSON SAFETY SYSTEMS ACQUISITION LLC | 2009-01-08 | — | — | US | disclosed |
| US-20090008002-A1 | Gas generant compositions | JOYSON SAFETY SYSTEMS ACQUISITION LLC | 2009-01-08 | — | — | US | disclosed |
| WO-2008060366-A2 | GAS GENERANT COMPOSITIONS | TK HOLDINGS, INC. (US) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090008002-A1 | Gas generant compositions | CBR3, CBR1, NOX5 | ALDH1A1 1527/4885KMT2A 1933/4885TSHR 745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.